Sep 2026· Advancement of science· 1 citation· 66 references
Medicine
TL;DR
A pH‐adaptive nanozyme platform (MICP@HG) is presented that orchestrates stage‐specific antibacterial and immunomodulatory activities throughout sepsis progression and elicits a vaccine‐like trained immunity effect that confers protection against reinfection.
Abstract
ABSTRACT Sepsis remains a leading cause of mortality because current therapies fail to address its dynamically evolving pathophysiology, in which infection, oxidative stress, and immune dysfunction emerge sequentially and interdependently. Here, we present a pH‐adaptive nanozyme platform (MICP@HG) that orchestrates stage‐specific antibacterial and immunomodulatory activities throughout sepsis progression. The platform integrates near‐infrared imaging, catalytic therapy, and immune regulation into a single construct. In acidic infectious microenvironments, the Cu–piceatannol shell exhibits peroxidase‐mimicking activity and induces cuproptosis‐like bacterial death through metabolic collapse and redox imbalance. As the microenvironment normalizes, the nanozyme shifts toward antioxidative and anti‐inflammatory functions via superoxide dismutase (SOD)‐ and catalase (CAT)‐like activities. Concurrently, the hyaluronic acid (HA)/β‐glucan coating facilitates infection‐targeted delivery and reprograms macrophages toward a reparative phenotype while restoring immune responsiveness. This dynamic functional transition enables efficient eradication of multidrug‐resistant bacteria, attenuation of systemic inflammation, and preservation of organ function, ultimately achieving complete survival in polymicrobial sepsis models. Notably, the platform also elicits a vaccine‐like trained immunity effect that confers protection against reinfection. This work establishes a paradigm for temporally programmed nanotherapy that aligns therapeutic function with disease progression, offering a precision strategy for the treatment of complex inflammatory disorders.
Sepsis is a life-threatening syndrome characterized by dysregulated immune responses and metabolic dysfunction, and remains a major cause of global mortality. While nanomedicine offers new opportunities for sepsis therapy, current strategies rarely achieve comprehensive modulation of macrophage immunometabolism and mic...
Xin-Tong Lu, Wen-Hui Wang, Bing-Jie Zhang et al.· Signal Transduction and Targ...· 0 citations
Abstract Sepsis is a complex and life-threatening syndrome driven by a dysregulated host response to infection, involving persistent oxidative stress, excessive inflammation, immune paralysis, metabolic disturbance, and progressive organ dysfunction. Although substantial advances have been achieved in supportive therap...
Ye-Sen Shou, Yu-Kun Liu, Xuan Zhao et al.· International Journal of Nan...· 0 citations
This review comprehensively evaluates the integration of sensing and therapy using nanoplatforms loaded with antibiotics, antimicrobial peptides, anti‐inflammatory agents, and gene‐regulatory molecules and highlights how these platforms optimize therapeutic windows by enhancing local drug bioavailability while minimizi...
Yu-Kun Liu, Kang Wang, Kwet Kyawl Yan et al.· Advancement of science· 0 citations
A mitochondrial targeted nanozyme (CuQ@SS31) is fabricated by coordinating copper with quercetin and modifying the mitochondria-homing peptide SS31 on the surface, which effectively alleviated oxidative stress, suppressed inflammation, and decelerated cartilage degradation, while demonstrating prolonged joint retention...
Jun-Hao Cui, Hai-Tao Han, Zhen-Tao Man et al.· Advanced Healthcare Material...· 0 citations
It is demonstrated that the integration of natural bioactivity with supramolecular engineering provides a biocompatible strategy for coordinated tumor-bacterial disruption and immunogenic remodeling of the F. nucleatum-associated tumor niche in CRC.
Ma-Liang Tao, Bin-Bin Wei, Yen-Yu Yang et al.· Advances in Materials· 0 citations
ABSTRACT Bacterial pneumonia treatment faces significant challenges due to uncontrolled inflammation and rising antibiotic resistance. Excessive inflammatory cytokine release and mitochondrial dysfunction exacerbate tissue damage, contributing to the disease's progression. Mitophagy, a process that eliminates dysfuncti...
Xiao-Feng Luo, Yun-Di Wu, Shuai Zhang et al.· Advancement of science· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.